Cardinal Partners

CHP Cardinal Partners, established in 1996, is a prominent venture capital firm based in Princeton, New Jersey, exclusively dedicated to healthcare investing. With a long-standing history, the firm has built a reputation for identifying and nurturing early-stage companies poised to revolutionize various sectors within the healthcare industry. Their investment thesis centers on backing innovative ideas in biotechnology, medical devices, diagnostics, and healthcare services, aiming to support ventures that address critical unmet medical needs or significantly improve patient care.

Over its more than two decades of operation, CHP Cardinal Partners has successfully raised and managed significant capital, accumulating over $1 billion in capital under management across six distinct funds. Their most recent fund, Cardinal Partners VI, closed in 2014 with $350 million, underscoring their consistent commitment to the healthcare sector. The firm's strategy involves not only providing financial backing but also leveraging its deep industry expertise and extensive network to guide portfolio companies through critical development stages, from clinical trials to market entry and commercialization.

CHP Cardinal Partners typically engages with companies at their early stages, often participating in seed or Series A rounds. While specific check sizes can vary based on the opportunity and stage, their initial investments generally range from approximately $3 million for promising seed-stage ventures to around $15 million for leading Series A rounds. The firm's portfolio reflects a diverse array of healthcare innovations, with a strong track record of successful exits through acquisitions and public offerings, demonstrating their ability to pick winners and generate substantial returns for their limited partners. Their long-term approach and specialized focus make them a key player in the healthcare venture capital landscape.